Glomerular mesangial cells can produce high amounts of nitric oxide (NO) and reactive oxygen species (ROS). Here we analyzed the impact of NO on the ROS-generating system, particularly on the NADPH oxidase Nox1. Nox1 mRNA and protein levels were markedly decreased by treatment of mesangial cells with the NO-releasing compound DETA-NO in a concentration-and time-dependent fashion. By altering the cGMP signaling system with different inhibitors or activators, we revealed that the effect of NO on Nox1 expression is at least in part mediated by cGMP. Analysis of a reporter construct comprising the 2547 bp of the nox1 promoter region revealed that a stimulatory effect of IL-1β on nox1 transcription is counteracted by an inhibitory effect of IL-1β-evoked endogenous NO formation. Moreover, pretreatment of mesangial cells with DETA-NO attenuated platelet-derived growth factor (PDGF)-BB or serum stimulated production of superoxide as assessed by real-time EPR spectroscopy and dichlorofluorescein formation. Transfection of mesangial cells with siRNAs directed against Nox1 and Nox4 revealed that inhibition of Nox1, but not Nox4 expression, is responsible for the reduced ROS formation by NO. Obviously, there exists a fine-tuned crosstalk between NO and ROS generating systems in the course of inflammatory diseases.
amplification as well as the maintenance of the inflammatory state (5) . Both NO and O 2 -can act as mediators of apoptosis and necrosis (6) , but they also trigger changes in the gene expression pattern of the cell by using well characterized signaling cascades (7) (8) (9) (10) . During the past decade great efforts were made in the understanding of the chemical interference of these small molecules and the biological consequences that arise from the state that is nowadays termed oxidative and nitrosative stress.
NO is generated by three isoforms of NO-synthases (NOS) that convert L-arginine to citrulline. The neuronal and endothelial isoforms (nNOS, eNOS) are regulated in their activity either by the availability of Ca ++ ions, or by phosphorylation. By contrast, the inducible form (iNOS) is induced by cytokines at the transcriptional level and can produce high amounts of NO over a long time-period that are responsible for apoptotic or necrotic cell death (11) (12) (13) . In mesangial cells, iNOS is induced by lipopolysaccharides, cytokines such as interleukin 1β (IL-1β) and tumor necrosis factor α (TNF-α), as well as by cyclic AMP (cAMP) (1, (14) (15) (16) . Remarkably, the mechanisms responsible for O 2 -formation are much more complex. A series of different enzymes (or enzyme systems) can catalyze the generation of O 2 -, among others the xanthine oxidase, the cyclooxygenases, the P450 cytochrome oxygenases, the NAD(P)H oxidases andunder certain circumstances-the NO synthases. In mesangial cells the NAD(P)H oxidase is currently thought to be the main producer of O 2 -, and this system is triggered by inflammatory cytokines and growth factors (2, 17).
NAD(P)H oxidases catalyze the reduction of two molecules of oxygen (O 2 ) to two molecules of O 2
-, whereby NADPH (or NADH) serves as the electron donor. This reaction has been thoroughly characterized in neutrophils where the production of O 2 -serves as a part of the innate immune defense system (18) . The electron transfer is catalyzed by the subunits gp91phox and p22phox, and this process is activated by the assembly of the cytosolic subunits p47phox, p67phox, p40phox, and the small G-protein Rac. Non-phagocytic cells use a similar machinery to generate O 2 - (19) . Interestingly, mesangial cells express all components required for functional NADPH oxidase systems, except from the catalytic subunit gp91phox (20) . Therefore, the existence of one or more alternative catalytic subunits in these cells was suspected to replace gp91phox. In fact, in 1999, Suh et al. (21) reported a mRNA species in vascular smooth muscle and colon carcinoma cells that encodes for a catalytically active subunit of the NADPH oxidase originally termed mitogenic oxygenase 1 (Mox1). In addition, a kidney NADPH oxidase isoform initially termed renal Nox (Renox) was characterized (22) . Meanwhile, some other gp91phox homologues from different tissues and cells were identified, and the nomenclature was accommodated. Mox1, gp91phox, and Renox are now termed Nox1, Nox2, and Nox4, respectively (23) . In contrast to Nox1 and Nox2, the Nox4 enzyme needs only the presence of p22phox for its activity. Assembly of Nox4/p22phox with the cytosolic components after phosphorylation by PKC or other kinases is not necessary and, therefore, Nox4 is constitutively active (24) . NO and O 2 -can neutralize each other by forming peroxynitrite. The temporal and spatial expression of iNOS and O 2 -generating enzymes determines whether O 2 -or NO trigger signaling cascades that may result in a proliferative or anti-proliferative state of the cell (21, 25) , which may control matrix formation or degradation (26, 27) or may finally end up in apoptosis or necrosis (6, 28) . In the course of glomerulonephritis, mesangial cells control, at least in part, proliferation, matrix formation, and cell death by generating inflammatory mediators, growth factors, NO and O 2 -. We found that NO as well as O 2 -can enhance cytokine-induced iNOS expression and NO formation (29, 30) in rat mesangial cells. Moreover, NO was reported to evoke the expression of Cu/Zn SOD (31) and extracellular Cu/Zn SOD (32), as well as MnSOD (33, 34) , and thus amplifies ROS metabolism. Furthermore, NO has been shown to directly inhibit NADPH-oxidase activity by disturbing the assembly process in neutrophils (35, 36) , but an action of NO on NADPH oxidase expression is not known to date. Recently, Gorin et al. reported the presence and activity of Nox4 in rat mesangial cells (37) . We performed this study to analyze whether Nox1 is also present in mesangial cells and whether these components of the NADPH oxidase system are under expressional control by NO.
MATERIALS AND METHODS

Reagents
Human recombinant IL-1β was from Cell Concept (Umkirch, Germany). Nylon blotting membranes were purchased from NEN Life Science Products (Köln, Germany), Immobilon P (PVDF) membranes from Millipore Eschborn, Germany. Media and sera were from Gibco-BRL (Eggstein, Germany), tissue culture plastic from Falcon (Becton Dickinson, Heidelberg, Germany).
, and N-omega-nitro-arginine methyl ester (L-NAME) were purchased from Alexis (Grünberg, Germany). Guanosine 3′, 5′-cyclic monophosphate, β-phenyl-1, N(2)-etheno-8-bromosodium salt (8-Br-PET-cGMP) was from Merck Biosciences (Schwalbach, Germany). Polyethylene glycol-superoxide dismutase (PEG-SOD) and all other chemicals were purchased from Sigma (Deisenhofen, Germany).
Freshly prepared stock solutions of CMH [20 mM dissolved in PBS containing 0.1 mM diethylenetriamine-pentaacetic acid (DTPA)] were purged with argon and kept on ice under argon. DTPA was used to decrease auto oxidation of CMH catalyzed by trace amounts of transition metals. The composition of modified Hepes-Tyrode solution was (mM): NaCl (132), HEPES (9.4), KCl (4), MgCl 2 (0.49), CaCl 2 (1), DTPA (0.1).
Cell culture
Rat glomerular mesangial cells (MC) were cultivated as described previously (38) and grown in RPMI 1640 medium supplemented with 10% fetal calf serum (FCS), 2 mM glutamine, 5 ng/ml insulin, 100 U/ml penicillin, and 100 µg/ml streptomycin. Quiescent cells were obtained by incubating MC for 24 h in serum-free Dulbecco's minimal essential medium (DMEM) supplemented with 0.1 mg/ml of essentially fatty acid-free bovine serum albumin before stimulation. MC were used between passages 12 and 18.
Real-time RT-PCR
Steady-state levels of Nox1 and Nox4 mRNA were analyzed by real-time, quantitative RT-PCR (Applied Biosystems, Weiterstadt, Germany) according to the manufacturers' protocol. Equal amounts of total RNA were reverse-transcribed with the reverse transcriptase (Invitrogen, Karlsruhe, Germany) using random hexamers. The oligonucleotides used for the real-time RT- Each 50 ng for the analysis of Nox1 or 5 ng for the analysis of 18S rRNA of the reversetranscribed cDNA were subjected to polymerase reaction using the GeneAmp 7700 sequence detection system (Applied Biosystems). The reactions were performed with 40 cycles (15 s at 95°C; 1 min at 62°C). Each sample was measured in triplicate. Quantification was performed according to the manufacturers' suggestions.
Determination of the nox1 transcriptional start site
The transcriptional start site of the nox1 gene was determined by RNA ligase mediated rapid amplification of cDNA ends (RLM-RACE) using a GeneRacer TM kit essentially according to the instructions of the manufacturer (Invitrogen, Karlsruhe, Germany). Because this method includes a procedure that removes truncated mRNA, it is expected that only full-length transcripts can be amplified. For the amplification of the nox1 5′ cDNA fragments nested PCR was performed using the nox1-specific oligonucleotides 5′ CTC GGG ATG GAA TAG GCT GGA GAG AAC A (external primer) and GTG GTT AAC CAG CCA GTT TCC CAT TGT C (internal primer) as well as the oligonucleotides specific for the ligated mRNA provided with the kit. PCR fragments were cloned into the vector pCRII-TOPO and sequenced using an automated sequence analyzer (Applied Biosystems, Weiterstadt, Germany).
Molecular cloning of the rat nox1 5′-flanking region
Using a genomic library "genome walker kit" containing adaptor-ligated genomic rat DNA fragments (BD Biosciences Clontech, Heidelberg, Germany), we cloned overall 2620 bp of the nox1 5′-flanking and sequenced after two rounds of genome walking. 2547 bp genomic DNA were then cloned in the MluI and XhoI sites of the luciferase reporter vector pGL3basic (Promega, Mannheim, Germany) and the plasmid obtained was further referred to as pGL3/3.
Transfection of mesangial cells with a nox1-promoter/luciferase reporter gene construct
Transfection of mesangial cells with pGL3/3 and pRL-TK used as a control was performed with the Effectene reagent (Qiagen, Hilden, Germany). Luciferase activity was measured using the dual reporter gene system (Promega).
Preparation of MC lysates for Nox1 characterization
Confluent mesangial cells in 10 cm-diameter dishes were stimulated for the indicated time periods in DMEM containing 0.1 mg/ml of fatty acid-free BSA, 5 µg/ml insulin, 100 U/ml penicillin, and 100 µg/ml streptomycin. To stop the reaction, the medium was removed and the cells were washed with ice-cold PBS. Cells were then scraped directly into lysis buffer (50 mM Tris-HCl, pH 7.5; 150 mM NaCl; 2 mM EDTA; 2 mM EGTA; 10% glycerol v/v; 1% Triton X-100 v/v; 40 mM α-glycerophosphate; 50 mM sodium fluoride; 10 mM sodium pyrophosphate and freshly added 10 µg/ml leupeptin; 10 µg/ml aprotinin; 10 µg/ml pepstatin A; 1 mM phenylmethylsulfonyl fluoride (PMSF); 1 mM DDT; 1 mM NaF; and 1 mM Na 3 VO 4 and homogenized by 10 passes through a 26-gauge needle fitted to a 1 ml syringe. The homogenate was centrifuged for 10 min at 13,000 × g and the supernatant was used for protein quantification. Aliquoted samples were stored at -80°C until use.
Generation and characterization of an anti-Nox1 antibody
The synthetic peptide CRRYSSLDPRKVQFYF representing amino acids 543-558 of the Nox1 protein (SwissProt Acc.No.: NP 446155) was synthesized, coupled to keyhole limpet hemocyanin, and used to immunize rabbits. For characterization of the antibody, MC lysates were separated on a CNBr-Sepharose column coupled with Nox1 antibody. Samples of 0.5 ml volume, containing the indicated amount of proteins, were diluted 1:1 with 10 mM Tris, pH 8.0, and loaded onto a Nox1-Sepharose column, three times regenerated with acetate buffer (100 mM Na-acetate, 0.5 M NaCl pH 4.0) and Tris-wash-buffer (100 mM Tris, 0.5 M NaCl, pH 8.0) and rotated overnight at 4°C. After centrifugation for 5 min at 3000 g samples were washed 3 times with a 10 mM Tris pH 8.0 and eluted with 100 mM glycine, pH 2.8, into 1.5 ml reaction tubes with 50 µl 2 M Tris, pH 8.25, for immediate neutralization. The eluted fractions were analyzed by Western blotting.
Western blot analysis
MC were lysed in homogenization buffer (125 mM Tris, pH 6.8; 4% SDS; 10% gylycerol; 2% β-mercaptoethanol; 1 mM NaF; 1 mM PMSF; 1 mM Na 3 VO 4 ; leupeptin (10 µg/ml); pepstatin A (10 µg/ml); aprotinin (10 µg/ml), and trypsin inhibitor (10 µg/ml). Extracts were boiled for 5 min and sonicated three times for 10 s. The protein concentration of the lysate was determined by the Micro BCA TM protein assay reagent kit (Pierce, Rockford, Ireland). Total protein (40 µg) from each sample was subjected to sodium dodecyl sulfate-PAGE (10% [wt/vol]). Subsequently, the protein was blotted onto a nylon membrane and immunoreactive protein was detected using an anti-Nox1 antibody (rabbit) and a secondary anti-rabbit-IgG antibody coupled to horseradish peroxidase. Immunoreactive bands were visualized by the chemiluminescence (ECL) system (Amersham) according to the company's specifications. Intensity of the bands representing Nox1 (75 kD) protein was evaluated using a GS-700 imaging densitometer (Bio-Rad, Munich, Germany).
Detection of O 2 -using EPR spectrometry
Growth-arrested mesangial cells in 10 cm plates were detached with Trypsin/EDTA and centrifuged at 1000 rpm. The cell pellets were resuspended in modified Hepes-Tyrode buffer (pH 7.5) with diethylenetriaminepentaacetic acid (DTPA; 0.1 mM). After a resting time of 15 min at 37°C the cells were pre-incubated with platelet derived growth factor (PDGF BB; 50 ng/ml) for 5 min, and the spin probe 1-hydroxy-3-methoxycarbonyl-2,2,5,5-tetramethylpyrrolidine hydrochloride (CMH) was added up to a final concentration of 2 mmol/L. To inhibit O 2 -formation, the cells were preincubated for 20 min with polyethylene glycol-superoxide dismutase (PEG-SOD; 50 units/ml). The cell suspension was quickly transferred into a 50 µl EPR capillary, For real-time recording of CM
• (nitroxide radical) formation, the intensity of the low field peak of the nitroxide triplet EPR signal was followed by using time scans with the following settings: microwave frequency, 9.72 GHz; modulation amplitude, 2 G; microwave power, 20 mW; conversion time, 655.36 ms; time constant, 81.92 ms; total time, 671.1 s.
Transfection of mesangial cells with siRNA and detection of ROS by dihydrodichlorofluorescein-DA
Mesangial cells were grown on 12-well plates and transfected with siRNA or scrambled (scr) against Nox1 (5′ sense: GAA GAG AGC AUG AGU GAA A 3′ and Nox4 (sense: 5′ GUA GGA GAC UGG ACA GAA A 3′), respectively, and grown in medium containing serum (8%) in the absence or presence of the NO donor DETA-NO (100 µM). After 24 h, cells were washed and incubated in Hepes-modified Tyrode's solution containing dihydrodichlorofluorescein-DA (5 µmol/L) for 20 min in the dark. Subsequently, formation of the oxidation product dichlorofluorescein was determined using a micro-plate fluorimeter (Wallac, Victor, excitation 488 nm, emission 515 nm). Experiments were performed in cells not deprived of serum in order to prevent the down-regulation of Nox1 by serum-deprivation.
Statistical analysis
Each experiment was performed at least three times. When appropriate, statistical analysis was performed using Student's t test or ANOVA (ANOVA) followed by Bonferroni's test. P-values <0.05 were considered significant.
RESULTS
To analyze the effects of NO on Nox1 mRNA levels, mesangial cells were stimulated for different time-points with DETA-NO (500 µM) or vehicle and the mRNA was subjected to realtime RT-PCR. A significant down-regulation of Nox1 mRNA levels was observed after 2 to 24 h (Fig. 1A) . The concentration-dependency of the NO effect was evaluated by stimulating mesangial cells with different amounts of DETA-NO (30-500 µM). A significant downregulation of Nox1 mRNA was observed already at a concentration of 30 µM (Fig. 1B) . Similar results were obtained when SNAP was used as a NO donor (data not shown).
Characterization of a Nox1 specific antibody
To be able to analyze NO-mediated Nox1 expression, an antibody was raised against the Nox1-derived peptide CRRYSSLDPRKVQFYF (SwissProt Acc. No.: NP 446135) in rabbit. The immuno-reactive band for Nox1 runs at a molecular weight of 75 kD. This is ~10 kD higher than expected from the computer-based translation of the respective cDNA. Whether this results from a posttranslational modification of Nox1 as recently suggested (40) is not yet known. To further characterize the Nox1 protein, we used an affinity chromatography approach. To this end Nox1 protein was purified by affinity chromatography using the same Nox1 antibody as for the Western blot experiments. The eluates of purified Nox1 protein were then subjected to Western blotting ( Fig. 2A) . To further characterize the specificity of the Nox1 antibody the purified antibody was compared with pre-immune serum and not purified immune serum. The Western blots experiments displayed in Fig. 2B clearly demonstrate an immuno-reactive band obtained with the purified antibody that was also present by use of the immune serum and that could not be detected when the blot was incubated with pre-immune serum. This clearly indicates the success of the purification procedure. To evaluate whether the antibody recognizes the peptide used for immunization blotted protein, extracts of mesangial cells were incubated with the purified antibody in the presence of a fivefold excess of the immunizing peptide before the blot was developed using the ECL system. The experiment shown in Fig. 2C clearly demonstrates that the peptide could completely block the binding of the purified Nox1 antibody.
Analysis of NO-modulated Nox1 protein expression
To evaluate whether DETA-NO-induced changes in mRNA expression are followed by changes in Nox1 protein levels, mesangial cells were treated with DETA-NO (500 µM) for different time-points. A marked reduction of Nox1 protein levels could be detected after 6 h DETA-NO treatment (Fig. 3A) . Treatment of mesangial cells with different concentrations of DETA-NO revealed that a concentration of 125 µM DETA-NO is sufficient to significantly reduce Nox1 protein levels (Fig. 3B, C) .
Involvement of soluble guanylyl cyclase (sGC) in NO-induced down-regulation of Nox1
To test, whether the activation of sGC is responsible for the NO-induced decrease in Nox1 expression, mesangial cells were stimulated with DETA-NO and sGC was blocked by coadministration of the sGC inhibitors ODQ or NS2028 (41) . The effects of cGMP on Nox1 expression were further analyzed by exposing MC to the NO independent sGC activator YC-1 (42) . As shown in Fig. 4A , ODQ and NS2028 clearly prevented and YC-1 mimicked the effects of DETA-NO on Nox1 mRNA expression. Similar results were obtained for Nox1 protein (Fig.  4B, C) . Furthermore, the membrane-permeable cGMP analog 8-Br-PET-cGMP dosedependently reduced Nox1 protein steady-state levels (Fig. 5) . Taken together, these findings show that activation of sGC and formation of cGMP is at least in part responsible for the downregulation of Nox1 by NO.
Nox1 protein expression in IL-1β-stimulated MC
To assess the influence of endogenously produced NO on Nox1 protein levels, mesangial cells were treated for 24 h with IL-1β (1 nM) in order to induce iNOS expression. Some cells were treated additionally with the NOS inhibitor N G -monomethyl-L-arginine (L-NMMA; 0.5 and 1.0 mM). Nox1 protein levels were detected by Western blotting. Interestingly, Nox1 protein expression was not affected by IL-1β compared with unstimulated control cells, but co-treatment of IL-1β-stimulated MC with L-NMMA resulted an increase in Nox1 protein levels indicating a down-regulation of Nox1 protein expression by endogenously produced NO (Fig. 6A, B) . To exclude an unspecific effect of L-NMMA, a further experiment using L-NAME as a NOS inhibitor was performed showing comparable results (data not shown). L-NMMA at a concentration of 1 mM had no effect on Nox1 expression when compared with controls in non IL-1β-stimulated cells (Fig. 6C ).
Page 7 of 24 (page number not for citation purposes)
Determination of the transcriptional start site of the nox1 gene
To analyze the 5′-flanking genomic sequences of the rat nox1 gene, we determined in a first step the transcriptional start site of the nox1 gene using a gene racer protocol. By sequencing a set of clones containing the 5′-nox1 cDNA revealed that the transcriptional start site was extended to 26 bp into the 5′-region (AGTACACTTATTCATTTTTGGAAGCT) compared with the published nox1 cDNA (GENBANK Acc.Nr. AF152963).
Cloning and analysis of the nox1 5′-flanking region
Overall, 2547 bp of genomic rat DNA representing the 5′-flanking region of the nox1 gene were cloned, sequenced, and fused to a luciferase gene in the vector pGL3basic. This construct is further referred to as pGL3/3. Computer-aided analysis of the nox1 promoter region revealed a series of putative binding sites for transcription factors, importantly also for DNA binding proteins like AP-1 and C/EBP that may be targeted by NO or its downstream signaling pathways. To analyze the effects of NO and IL-1β on nox1 promoter activity, mesangial cells were transfected with pGL3/3 and stimulated with IL-1β and/or different activators or inhibitors of the NO/cGMP pathway for 24 h as indicated (Fig. 7) and luciferase activity was measured as a readout for nox1 promoter activity.
Treatment of pGL3/3-transfected mesangial cells with IL-1β significantly induced nox1 promoter activity and this effect was further enhanced, when IL-1β-evoked nitric oxide production was blocked by L-NMMA indicating an inhibitory role for endogenous NO on nox1 promoter activity. Interestingly, DETA-NO (125 µM) significantly reduced luciferase activity to less than 50%, whereas all treatments using sGC activator or inhibitors had no effect indicating a cGMP-independent NO-mediated redox-sensitive pathway acting on nox1 transcription.
Effect of DETA-NO on superoxide formation in mesangial cells
To test whether the NO-induced decrease of Nox1 expression translates into a corresponding decrease in NADPH oxidase activity, we analyzed the effect of DETA-NO treatment (8 h, 125 µM) on O 2 -production in mesangial cells. To this end, DETA-NO treated or untreated (control) MC were detached from the culture plate, suspended in Hepes-Tyrode solution, and incubated with or without platelet-derived growth factor BB (PDGF-BB; 50 ng/ml), in the absence or presence of PEG-SOD (50 units/ml). After 5 min, O 2 -was trapped by CMH (2 mM) for 10 min (43). Oxidation of the spin probe CMH by reactive oxygen species (peroxynitrite, superoxide) forms the stable 3-methoxyproxyl nitroxide radical (CM • ). The SOD-sensitive part of CM • radical formation is a specific measure of O 2 -formation. The cell suspension was quickly transferred into an EPR capillary tube, and EPR recordings started immediately at room temperature, either by field scan, or for real-time recording of superoxide formation by continuous monitoring of the low-field line of the triplet EPR signal (Fig. 8A ).
In the presence of non-stimulated MC CM • , nitroxide radical generation proceeded for 10 min at a constant rate, as indicated by the steady increase in EPR signal intensity ("basal"). This rate exceeded spontaneous CM
• nitroxide radical formation in Hepes-Tyrode's solution in the absence of cells (data not shown). After stimulation with PDGF (Fig. 8A ) cells generated CM
• radicals at a higher rate ("PDGF"). Addition of SOD decreased this rate to the rate observed with non-
Page 8 of 24 (page number not for citation purposes)
stimulated cells in the presence of SOD. Fig. 8B shows the summarized SOD-sensitive (= superoxide-dependent) CM
• radical generation from 4 batches of DETA-NO treated and control mesangial cells. DETA-NO pretreatment of mesangial cells significantly (P<0.05, Student's t test) decreased PDGF-elicited superoxide formation (open columns) as compared with controls (closed columns). Basal superoxide formation was not different between DETA-NO-exposed and control cells (Fig. 8B) .
Effects of Nox-specific siRNAs on ROS production in mesangial cells
In cells grown in the presence of serum, siRNA directed against Nox1 inhibited serum-induced radical formation as determined by dihydrodichlorofluorescein oxidation by 19.4 ± 4.9% (P<0,05) whereas Nox4 siRNA was without effect. Pretreatment of cells with the NO-donor DETA-NO impaired the radical formation in cells transfected with scrambled siRNA by approx. 22%. siRNA directed against Nox4 had only a small, nonsignificant effect of the NO-induced inhibition of radical formation. In contrast, in cells treated with Nox1 siRNA, no NO-induced inhibition was observed anymore (Fig. 9) .
DISCUSSION
Inflammation is a complex and tightly regulated sequence of events that starts with an initial formation of proinflammatory factors that recruit immune cells to clear the offending trigger. A second anti-inflammatory phase follows in which resident cells, located mainly in the renal glomerulus, acquire the potential for protecting themselves from further activation and injury (10) .
Endogenous free radicals are thought to play crucial functions in renal diseases (3, 4, 28) . NO and O 2 -are simple molecules with unpaired electrons that are generated as a host defense mechanism in various cell types in inflammatory diseases (44) . These radicals act not only as cytotoxic agents but also as important physiological or pathophysiological mediators of proliferative, apoptotic, vasoregulatory, or inflammatory signaling cascades (7) (8) (9) . NO antagonizes O 2 -at different levels: it neutralizes O 2 -by forming peroxynitrite, and it reduces O 2 -production by inhibiting directly the NADPH oxidase enzyme activity (35, 36) . Under certain conditions, NO has been reported to render cells resistant to oxidative stress (45) . This also underscores the need for an intricate balance between NO and O 2 -for cellular fidelity. Most importantly, NO and O 2 -also have an impact on the expression and activity of enzymes that either generate or metabolize both types of radicals. Indeed, one of the first genes identified as a target for transcriptional regulation by NO was iNOS (29) , suggesting that NO modulates its own biosynthetic machinery. This potent amplification mechanism may form the basis for the excessive formation of NO in acute inflammatory processes and its in vivo relevance has been reported (10) . Moreover, superoxide also potently amplifies iNOS expression and NO production (30) . However, the role of NO in regulating gene expression of NADPH oxidase has not been investigated, so far.
To get more insight into the complex cross-talk between the O 2 - and NO generating systems we tested the effects of NO on the expression of the NADPH oxidase subunit Nox1 as well as the activity of the NADPH oxidase. Stimulation of mesangial cells with the NO donor DETA-NO led to the down-regulation of Nox1 mRNA levels in a time-and dose-dependent manner.
Similarly, Nox1 protein expression also decreased dose-dependently. Pre-stimulation with DETA-NO significantly reduced PDGF-induced ROS production indicating a functional role for NO-dependent down-regulation of Nox1. Basal superoxide formation was not different between DETA-NO-treated and control cells (Fig. 8) . This finding suggests either that other sources besides NADPH oxidase account for basal superoxide formation, or that down-regulation of Nox1 limits PDGF-elicited, not basal NADPH oxidase activity.
Already low amounts of DETA-NO significantly decreased Nox1 mRNA levels after 6 h by 50%, as assessed by real-time PCR (Fig. 1B) . These concentrations of DETA-NO generate steady state NO concentrations of ~0. (46) . Since sGC is a high-affinity receptor for NO and is half-maximally activated at this steady-state concentration of NO (47), we wondered whether sGC activation accounts for the NO-induced depression of Nox1. Using specific inhibitors (ODQ and NS2028) (41) and the stable cGMP analog 8-Br-PET-cGMP as well as the NO-independent activator (YC-1) (42) of sGC, we could show that indeed sGC activation is involved in the down-regulation of Nox1. We have shown recently that cGMP depresses the mRNA stabilizing protein HuR, thereby conferring destabilization of HuR target mRNAs like sGC (48) and MMP-9 (27) . Rat Nox1 bears several AU-rich elements in its 3′UTR, which are potential binding sites for endonucleases and HuR. It is therefore conceivable that mRNA destabilization could account at least in part for the cGMP-dependent decrease in Nox1 expression.
Interestingly, treatment of MC with IL-1β to force induction of endogenous NO formation did not significantly change Nox1 expression. However, blockage of NO production in IL-1β stimulated cells resulted in a marked increase in Nox1 protein expression (Fig. 6) . To get deeper insight in the mechanistic details of nox1 transcription, we cloned and fused the 5′-flanking region of the nox1 gene to a luciferase reporter gene. Mesangial cells, transfected with the respective DNA construct, reacted to IL-1β with an activation of the nox1 promoter as assessed by measurement of luciferase activity. By contrast, administration of DETA-NO diminished luciferase activity compared with untreated controls, indicating that IL-1β and NO counteract each other for nox1 expression (Fig. 7) . Interestingly, transcriptional regulation of the nox1 gene is obviously not influenced by the cGMP pathway. This further suggest that NO dually affects O 2 -formation and additionally affects Nox1 expression posttranscriptionally in a cGMPdependent manner.
The bioactivity of O 2 -reflects its rates of production by NADPH-oxidases, xanthine oxidase, or other pathways and its inactivation by superoxide dismutases (SODs). Frank et al. (31) first identified Cu/ZnSOD as a novel NO-regulated gene in renal mesangial cells and in kidneys of endotoxemic rats. The authors proposed that up-regulation of Cu/ZnSOD by endogenous NO may serve as an adaptive, protective mechanism to prevent formation of toxic quantities of peroxynitrite in conditions associated with iNOS induction.
Based on our observations and the reports of others, we assume that mesangial cell try to shift the balance of reactive oxygen and nitrogen species to the NO side to circumvent deleterious effects of O 2 -. They do so by two mechanisms, a down-regulation of O 2 -formation by suppression of Nox1 expression and by simultaneous up-regulation of O 2 -dismutating SODs. In the inflammatory state, this could result in a protective pathway even when only low amounts of NO are available within the inflamed tissue. The fine-tuning of the spatial and temporal O 2 -and NO production will determine the outcome of an inflammatory process and may offer therapeutic intervention strategies.
The existence of a family of NAD(P)H oxidases that mediate ROS production raises the question which of these enzymes trigger ROS production in mesangial cells. In 1991, Radeke et al. (17) demonstrated the existence of an active NADPH oxidase in human mesangial cells. While this work is still the first proof for a fully active NADPH oxidase in non-phagocytic cells with respect to the electron transfer capabilities, these data do not exclude that the confirmed NADPH oxidase activity in human mesangial cells is based on one of the recently newly identified Nox isoforms. In line with the observation of Jones et al. (20) we could not detect mRNA for Nox2 in total RNA of mesangial cells by RT-PCR using primers that are specific of Nox2 mouse and rat cDNA and that produced a clear and intensive band when total RNA of rat small intestine tissue or mouse RAW macrophages were used as a template (data not shown). -. Using quantitative RT-PCR, we could also observe a down-regulation of Nox4 mRNA steady-state levels in rat mesangial cells that was well coordinated with the down-regulation of Nox1 mRNA (M. Pleskova, unpublished observations). However, we performed two experiments that favor Nox1 as the responsible enzyme for the observed reduction of ROS formation in the presence of DETA-NO. First, as recently described, Nox4 requires only the presence of p22phox to be fully active (24, 49) and has, therefore, not to be activated by kinases. As depicted in Fig. 8 , only PDGF-induced and not basal ROS formation is significantly affected by pretreatment of mesangial cells with DETA-NO. Second, siRNA directed against Nox1 abrogated the DETA-NO-mediated inhibition of ROS formation (Fig. 9) . By contrast, siRNA directed against Nox4 was not significantly effective in this regard. Both observations clearly suggest that downregulation of Nox1 is responsible for the observed reduction of ROS formation by NO. Further in vivo and in vitro studies are necessary to further clarify the role of Nox isoforms in growth, differentiation and inflammation. for the indicated time periods with DETA-NO (500 µM). Total RNA (each 1 µg) was reversed-transcribed, and each 50 ng was analyzed for Nox1 mRNA and 5 ng for 18S rRNA by real-time PCR using a GeneAmp 7700 System (Applied Biosystems). The results of three independent experiments are displayed in (A) as % of reduction vs. control (means +/-SD.; *P < 0.05, **P < 0.01, ***P < 0.001 versus control). To evaluate the concentration dependency, quiescent mesangial cells were treated with the indicated concentrations of DETA-NO for 6 h. The results of three independent experiments are expressed as % of reduction vs. control (B). (A, B) . Each 50 µg total protein of mesangial cells was subjected to Western blotting using the pre-immune serum, immune serum, and affinity-purified antibody against Nox1. C) Each 50 µg total protein of mesangial cells was subjected to PAGE/SDS gel electrophoresis and Western blotting. Lanes 1 and 2 were incubated for 15 h with the purified anti-Nox1 antibody and additionally a five-fold excess of the peptide used for immunization. Lanes 3 and 4 were incubated for 15 h with the purified anti-Nox1 antibody. with 500 µM DETA-NO (A) or for 8 h with the indicated concentrations of DETA-NO (B). Thereafter, total protein was isolated, and each 40 µg protein was subjected to SDS-PAGE. Then the gel was blotted onto an immobilon membrane using a BioRad Semi-dry system. Analysis of Nox1 expression was achieved with the polyclonal antibody described in Materials and Methods. A representative blot from three similar experiments is shown in (A). The dose-dependency of the NO effect on Nox1 protein expression is shown in (B). The densitometric analysis of three independent experiments is expressed as % of reduction vs. control and is displayed as means +/-SD. (**P<0.01 versus control) (C). 
